• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

可预测透明细胞肾细胞癌的不良预后。

can predict the poor prognosis of clear cell renal cell carcinoma.

作者信息

Gan Xinqiang, Liu Ruiji, Cheng Hong, Mao Weipu, Feng Ninghan, Chen Ming

机构信息

Department of Urology, People's Hospital of Putuo District, Shanghai, China.

Department of Urology, Affiliated Zhongda Hospital of Southeast University, Nanjing, China.

出版信息

Front Oncol. 2022 Aug 16;12:882888. doi: 10.3389/fonc.2022.882888. eCollection 2022.

DOI:10.3389/fonc.2022.882888
PMID:36052245
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9424662/
Abstract

PURPOSE

Clear cell renal cell carcinoma (ccRCC) is one of the most common malignancies of the urinary system. This study was conducted to discover a new target that can predict the prognosis and promote the treatment of ccRCC.

METHODS

The raw data were downloaded from the TCGA database, and the predictive value of for various clinicopathological features was verified in the following analysis. Then, we analyzed the potential involvement of in tumor immunity and obtained the possible pathways involving through GO/KEGG enrichment analysis and GSEA. We also further verified our findings in pathological specimens of ccRCC patients.

RESULTS

expression was significantly increased in ccRCC, which was associated with advanced clinicopathological characteristics. It was an independent prognostic factor for overall survival in 535 patients with ccRCC. Immune cell infiltration analysis revealed that expression was related to T lymphocyte infiltration of tumors and poor prognosis. Moreover, we performed relevant functional enrichment analyses of .

CONCLUSIONS

might play a significant role in the development and immune cell infiltration of ccRCC and serve as a valuable clinical prognostic biomarker.

摘要

目的

透明细胞肾细胞癌（ccRCC）是泌尿系统最常见的恶性肿瘤之一。本研究旨在发现一个能够预测ccRCC预后并促进其治疗的新靶点。

方法

从TCGA数据库下载原始数据，并在后续分析中验证其对各种临床病理特征的预测价值。然后，我们分析了其在肿瘤免疫中的潜在作用，并通过GO/KEGG富集分析和GSEA获得了与之相关的可能途径。我们还在ccRCC患者的病理标本中进一步验证了我们的发现。

结果

在ccRCC中表达显著增加，这与晚期临床病理特征相关。它是535例ccRCC患者总生存的独立预后因素。免疫细胞浸润分析显示，其表达与肿瘤的T淋巴细胞浸润及不良预后相关。此外，我们对其进行了相关的功能富集分析。

结论

可能在ccRCC的发生发展及免疫细胞浸润中起重要作用，并可作为有价值的临床预后生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/db9377889b8b/fonc-12-882888-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/c00c8ec84eb2/fonc-12-882888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/ff88be693441/fonc-12-882888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/db58e6ea64ee/fonc-12-882888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/7f3a28d83578/fonc-12-882888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/8563d2931751/fonc-12-882888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/50af4b7580fd/fonc-12-882888-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/32464d89177a/fonc-12-882888-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/1ebd68694a9f/fonc-12-882888-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/db9377889b8b/fonc-12-882888-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/c00c8ec84eb2/fonc-12-882888-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/ff88be693441/fonc-12-882888-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/db58e6ea64ee/fonc-12-882888-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/7f3a28d83578/fonc-12-882888-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/8563d2931751/fonc-12-882888-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/50af4b7580fd/fonc-12-882888-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/32464d89177a/fonc-12-882888-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/1ebd68694a9f/fonc-12-882888-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4409/9424662/db9377889b8b/fonc-12-882888-g009.jpg

相似文献

1
can predict the poor prognosis of clear cell renal cell carcinoma.可预测透明细胞肾细胞癌的不良预后。
Front Oncol. 2022 Aug 16;12:882888. doi: 10.3389/fonc.2022.882888. eCollection 2022.
2
A comprehensive analysis of MYO6 as a promising biomarker for diagnosis, prognosis, and immunity in clear cell renal cell carcinoma.对MYO6作为透明细胞肾细胞癌诊断、预后和免疫的有前景生物标志物的综合分析。
Transl Cancer Res. 2023 Aug 31;12(8):2071-2098. doi: 10.21037/tcr-23-227. Epub 2023 Aug 23.
3
associates with cancer metabolism and immune infiltration in clear cell renal cell carcinoma: a retrospective prognostic study based on the TCGA database.与透明细胞肾细胞癌的癌症代谢和免疫浸润相关：一项基于TCGA数据库的回顾性预后研究
Transl Cancer Res. 2022 Jul;11(7):2321-2337. doi: 10.21037/tcr-22-1488.
4
Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma.白细胞介素 20 受体亚基 β（IL20RB）预测透明细胞肾细胞癌的不良预后并调节免疫细胞浸润。
BMC Genom Data. 2022 Jul 26;23(1):58. doi: 10.1186/s12863-022-01076-4.
5
Exploration of the relationships between tumor mutation burden with immune infiltrates in clear cell renal cell carcinoma.透明细胞肾细胞癌中肿瘤突变负荷与免疫浸润之间关系的探索。
Ann Transl Med. 2019 Nov;7(22):648. doi: 10.21037/atm.2019.10.84.
6
Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma.对预后和免疫相关的阅读蛋白EIF3A在透明细胞肾细胞癌中的作用进行系统分析。
Cancer Cell Int. 2021 Dec 19;21(1):680. doi: 10.1186/s12935-021-02364-2.
7
PPARα gene is a diagnostic and prognostic biomarker in clear cell renal cell carcinoma by integrated bioinformatics analysis.通过综合生物信息学分析，PPARα基因是透明细胞肾细胞癌的一种诊断和预后生物标志物。
J Cancer. 2019 May 22;10(10):2319-2331. doi: 10.7150/jca.29178. eCollection 2019.
8
Survival Prognosis, Tumor Immune Landscape, and Immune Responses of ADAMTS14 in Clear Cell Renal Cell Carcinoma and Its Potential Mechanisms.透明细胞肾细胞癌中 ADAMTS14 的生存预后、肿瘤免疫图谱和免疫反应及其潜在机制。
Front Immunol. 2022 Apr 29;13:790608. doi: 10.3389/fimmu.2022.790608. eCollection 2022.
9
FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma.FAM72家族蛋白作为透明细胞肾细胞癌的不良预后标志物
Biochem Biophys Rep. 2023 Jul 6;35:101506. doi: 10.1016/j.bbrep.2023.101506. eCollection 2023 Sep.
10
Comprehensive analysis of subunit expression, prognostic value, and immune infiltration in clear cell renal cell carcinoma.透明细胞肾细胞癌中亚基表达、预后价值及免疫浸润的综合分析
Transl Androl Urol. 2024 Aug 31;13(8):1517-1536. doi: 10.21037/tau-24-95. Epub 2024 Aug 26.

引用本文的文献

1
FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production.FAM50A通过与C9ORF78相互作用驱动乳腺癌脑转移，以增强L-天冬酰胺的产生。
Sci Adv. 2025 Jun 20;11(25):eadt3075. doi: 10.1126/sciadv.adt3075. Epub 2025 Jun 18.
2
Metabolic signature of renal cell carcinoma tumours and its correlation with the urinary metabolome.肾细胞癌肿瘤的代谢特征及其与尿液代谢组的相关性。
Metabolomics. 2025 Feb 13;21(2):26. doi: 10.1007/s11306-024-02212-0.
3
Metabolomic landscape of renal cell carcinoma in von Hippel-Lindau syndrome in a Chinese cohort.

本文引用的文献

1
BAP1-Related ceRNA (NEAT1/miR-10a-5p/SERPINE1) Promotes Proliferation and Migration of Kidney Cancer Cells.BAP1相关的竞争性内源RNA（NEAT1/miR-10a-5p/SERPINE1）促进肾癌细胞的增殖和迁移。
Front Oncol. 2022 Mar 29;12:852515. doi: 10.3389/fonc.2022.852515. eCollection 2022.
2
Metastatic Immune-Related Genes for Affecting Prognosis and Immune Response in Renal Clear Cell Carcinoma.影响肾透明细胞癌预后和免疫反应的转移性免疫相关基因
Front Mol Biosci. 2022 Jan 28;8:794326. doi: 10.3389/fmolb.2021.794326. eCollection 2021.
3
Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional, Propensity Score Matching Cohort Study.
中国队列中冯·希佩尔-林道综合征肾细胞癌的代谢组学特征
iScience. 2024 Jun 22;27(7):110357. doi: 10.1016/j.isci.2024.110357. eCollection 2024 Jul 19.
改良晚期肺癌炎症指数在接受腹腔镜肾切除术的肾细胞癌患者中的预后意义：一项多机构、倾向评分匹配队列研究
Front Nutr. 2022 Jan 20;8:781647. doi: 10.3389/fnut.2021.781647. eCollection 2021.
4
Identification of a Novel Defined Immune-Autophagy-Related Gene Signature Associated With Clinical and Prognostic Features of Kidney Renal Clear Cell Carcinoma.一种与肾透明细胞癌临床和预后特征相关的新型免疫自噬相关基因特征的鉴定
Front Mol Biosci. 2021 Dec 20;8:790804. doi: 10.3389/fmolb.2021.790804. eCollection 2021.
5
ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma.环状 RNA （ ciRS-7 ）是肾细胞癌的预后生物标志物和潜在的基因治疗靶标。
Mol Cancer. 2021 Nov 5;20(1):142. doi: 10.1186/s12943-021-01443-2.
6
Relationship Between Pre-operative Blood Glucose Level and Length of Hospital Stay in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy.接受腹腔镜肾切除术的肾细胞癌患者术前血糖水平与住院时间的关系
Front Surg. 2021 May 24;8:659365. doi: 10.3389/fsurg.2021.659365. eCollection 2021.
7
GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA.GEPIA2021：将多种基于去卷积的分析整合到 GEPIA 中。
Nucleic Acids Res. 2021 Jul 2;49(W1):W242-W246. doi: 10.1093/nar/gkab418.
8
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020：全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
9
TIMER2.0 for analysis of tumor-infiltrating immune cells.TIMER2.0 用于分析肿瘤浸润免疫细胞。
Nucleic Acids Res. 2020 Jul 2;48(W1):W509-W514. doi: 10.1093/nar/gkaa407.
10
Extent and characteristics of immune infiltration in clear cell renal cell carcinoma and the prognostic value.透明细胞肾细胞癌中免疫浸润的程度、特征及预后价值
Transl Androl Urol. 2019 Dec;8(6):609-618. doi: 10.21037/tau.2019.10.19.